Sirtuin 5:a review of structure,known inhibitors and clues for developing new inhibitors

• 作 者: Lingling Yang Xiaobo Ma Yanying He Chen Yuan Quanlong Chen Guobo Li Xianggui Chen
• 机 构: College of Food and Bioengineering,Xihua University,Key Laboratory of Drug Targeting and Drug Delive
• 出 处: Science China(Life Sciences)
• 发表日期: 2017年03期
• 关键词: dinucleotide nicotinamide adipocyte expenditure summarized deacetylase adenine f

Sirtuins(SIRTs) are nicotinamide adenine dinucleotide(NAD~+)-dependent protein deacetylases,which regulate important biological processes ranging from apoptosis,age-associated pathophysiologies,adipocyte and muscle differentiation,and energy expenditure to gluconeogenesis.Very recently,sirtuin 5(SIRT5) has received considerable attention due to that it was found to have weak deacetylase activity but strong desuccinylase,demalonylase and deglutarylase activities,and it was also found to be associated with several human diseases such as cancer,Alzheimer’s disease,and Parkinson’s disease.In this review,we for the first time summarized the structure characteristics,known peptide and small-molecule inhibitors of SIRT5,extracted some clues from current available information and introduced some feasible,practical in silico methods,which might be useful in further efforts to develop new SIRT5 inhibitors.

Sirtuins (SIRTs) are nicotinamide adenine dinucleotide (NAD ~ +) - dependent protein deacetylases, which regulate the biological processes ranging from apoptosis, age-associated pathophysiology, adipocyte and muscle differentiation, and energy expenditure to gluconeogenesis. ) has received especially attention due to that it was found to have weak deacetylase activity but strong desuccinylase, demalonylase and deglutarylase activities, and it was also found to be associated with several human diseases such as cancer, Alzheimer’s disease, and Parkinson’s disease. this review, we for the first time summarized in structure characteristics, known peptide and small-molecule inhibitors of SIRT5, extracted some clues from current available information and introduced some feasible, practical in silico methods, which might be useful in further efforts to develop new SIRT5 inhibitors.